Literature DB >> 28878867

Prevalence of Squamous Cell Carcinoma of the Esophagus in a Single Tertiary Center of South Africa: A Cross Sectional Analytic Study.

Mpho Kgomo1, Ali A Elnagar1, Jaco Nagel1, Taole Mokoena2.   

Abstract

The incidence of esophageal cancer varies widely in the world. In the Middle East, Africa, and Asia and parts of Europe, squamous cell carcinoma of the esophagus dominates the esophageal cancer landscape. Worldwide the rates are highest in Northern China, South Africa, Turkey and Iran. In the United States, the black population has a five-fold higher incidence of esophageal squamous cell carcinoma than the white population. To determine the prevalence of squamous cell carcinoma of the esophagus in a single tertiary center in South Africa. Patients referred to Gastroenterology Division of Steve Biko Academic Hospital for upper gastrointestinal endoscopy were recruited. Those with a known diagnoses of squamous cell carcinoma of the esophagus were recorded and those with suspicious lesions had biopsies done. These were then evaluated by an experienced histopathologist. 6118 patients were recruited. Squamous cell carcinoma was found in 59 patients giving us a prevalence of 0.96% 95%CI. The cancer was found mainly in back elderly males. The prevalence of squamous cell carcinoma of the esophagus in this single center study is 0.96%, 95% confidence interval and is a disease of black elderly males as seen elsewhere. Bigger multicenter studies are needed to further clarify this findings.

Entities:  

Keywords:  esophagus; prevalence; squamous cell carcinoma

Year:  2017        PMID: 28878867      PMCID: PMC5575454          DOI: 10.4081/jphia.2017.563

Source DB:  PubMed          Journal:  J Public Health Afr        ISSN: 2038-9922


Competing interest statement

Conflict of interest: the authors declare no potential conflict of interest.

Introduction

The incidence of esophageal cancer varies widely in the world. In the Middle East, Africa, and Asia and parts of Europe, Squamous cell carcinoma of the esophagus dominates the esophageal cancer landscape. Worldwide the rates are highest in Northern China, South Africa, Turkey and Iran.[1] In the United States, the black population has a five-fold higher incidence of esophageal squamous cell carcinoma (ESCC) than the white population.[1] Esophageal cancer is the eighth most frequent cancer in the world, it occurs in two subtypes, adenocarcinoma and squamous cell carcinoma which is more prevalent in developing countries including South Africa.[2] Risk factors for squamous cell carcinoma include smoking, alcohol consumption and human papilloma virus infection.[3] Squamous cell carcinoma occur in high incidence in many parts of Africa especially in the eastern parts of the continent.[4-6] It presents a significant health problem because the development of the disease is asymptomatic resulting in late diagnosis and poor prognosis.[7] The 5 year survival of squamous cell carcinoma of the esophagus is less than 10%, a statistic that has remained unchanged for 30 years.[7] One of the striking features of esophageal squamous cell carcinoma is the presence of defined geographic regions with populations displaying high incidence of this disease. These include areas such as the Linxian District in China, parts of Iraq and Iran, areas in South America, regions in South Africa, East and Central Africa.[4,6,8,9] In Africa, as in other parts of the world with high incidence of esophageal cancer, smoking and alcohol consumption feature as the most common risk factors for esophageal cancer,[3,10] while areas with low tobacco consumption display low frequencies of esophageal cancer.[11] T. van der Merwe and colleagues showed a 52% decrease in the number of newly diagnosed cases of esophageal cancer in Bloemfontein from 1995 to 2005 and attributed this to the emergence of HIV/AIDS epidemic in Southern Africa which lead to early death at a young age before the age at which esophageal cancer occur which is around 60 years.[11-13] Most HIV related deaths occur between 25-44 years of age in South Africa.14. The highest mortality rate of ESCC are found in East Asia, Southern and Eastern Africa where patients present late.[6]

Materials and Methods

Consecutive patients referred to Gastrointestinal Division of Steve Biko Academic Hospital for upper gastrointestinal endoscopy were recruited over a two year period. A written informed consent for endoscopy and biopsy was obtained from each patient. A proper history was obtained to identify those with significant gastrointestinal disease. Biopsies were taken from patients with esophageal lesions suspected to be esophageal cancer and not yet confirmed to be cancer by previous endoscopy, those already diagnosed with cancer prior to referral were recorded. The biopsies were examined by an experienced histopathologist. Most of the patients with suspected cancer had advanced incurable lesions with only palliative therapy possible.

Results

Six thousand one hundred and eighteen (6118) patients ranging in age from 27 to 87 were recruited. Squamous cell carcinoma of the esophagus was found in 59 patients. They consisted of forty five males and fourteen females. All patients were from South Africa. The racial distribution was 54 black South Africans and 5 Caucasians. This gives us a prevalence of 0.96% with 95% confidence interval (Table 1).
Table 1.

Prevalence of squamous cell carcinoma of the esophagus: race and gender distribution.

GenderRace
MaleFemaleBlackCaucasian
Number4514545
%7623919
Again this study confirms that squamous cell carcinoma of the esophagus is a disease of black middle aged to elderly black males.

Discussion and Conclusions

The prevalence of squamous cell carcinoma of the esophagus in this one tertiary center was found to be 0.96% similar to figures given by the South African National Cancer Registry in 2010, and it is a disease of middle aged to elderly black men. The prevalence of esophageal squamous cell carcinoma during this period is 0.96%. Unfortunately we have no previous figures from this center to compare to however the study confirms findings from other centers that it is still a disease of black men. The prevalence increases with age to peak at the 7th to 8th decade (Table 2 and Figure 1).
Table 2.

Prevalence of squamous cell carcinoma of the esophagus: age distribution.

3rd decade4th decade5th decade6th decade7th decade8th decade
0 (0%)6 (10%)14 (23%)16 (27%)20 (34%)3 (5%)
Figure 1.

Prevalence of squamous cell carcinoma: age distribution.

Limitations of this study is that other risk factors such as cigarette smoking and alcohol were not looked for. The South African cancer registry is currently not up to date again giving us nothing to compare to but figures as similar to 2010. Black race, male and advancing age are again risk factors as shown here.
  11 in total

Review 1.  Incidence, epidemiology, and etiology of esophageal cancer.

Authors:  Z Gamliel
Journal:  Chest Surg Clin N Am       Date:  2000-08

2.  Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Authors:  Gabriele Nagel; Jakob Linseisen; Hendriek C Boshuizen; Guillem Pera; Giuseppe Del Giudice; Gert P Westert; H Bas Bueno-de-Mesquita; Naomi E Allen; Timothy J Key; Mattijs E Numans; Petra Hm Peeters; Sabina Sieri; Henrik Siman; Goran Berglund; Goran Hallmans; Roger Stenling; Carmen Martinez; Larraitz Arriola; Aurelio Barricarte; M Dolores Chirlaque; Jose R Quiros; Paolo Vineis; Giovanna Masala; Domenico Palli; Salvatore Panico; Rosario Tumino; Sheila Bingham; Heiner Boeing; Manuela M Bergmann; Kim Overvad; Marie-Christine Boutron-Ruault; Francoise Clavel-Chapelon; Anja Olsen; Anne Tjonneland; Antonia Trichopoulou; Christina Bamia; Stavroula Soukara; Jean-Christoph Sabourin; Fatima Carneiro; Nadia Slimani; Mazda Jenab; Teresa Norat; Elio Riboli; Carlos A González
Journal:  Int J Epidemiol       Date:  2007-01-16       Impact factor: 7.196

3.  Squamous cell cancer of the esophagus: the forgotten one.

Authors:  Lawrence Leichman; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2011-01

Review 4.  Molecular biology of esophageal squamous cell carcinoma.

Authors:  A K Lam
Journal:  Crit Rev Oncol Hematol       Date:  2000-02       Impact factor: 6.312

5.  Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.

Authors:  H R Wabinga; D M Parkin; F Wabwire-Mangen; J W Mugerwa
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

Review 6.  Oesophageal cancer in Africa.

Authors:  Denver Hendricks; M Iqbal Parker
Journal:  IUBMB Life       Date:  2002 Apr-May       Impact factor: 3.885

7.  An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus.

Authors:  Bas P L Wijnhoven; Khe T C Tran; Adrian Esterman; David I Watson; Hugo W Tilanus
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

Review 8.  Research on esophageal cancer in China: a review.

Authors:  C S Yang
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

9.  Risk factors associated with oesophageal cancer in Bulawayo, Zimbabwe.

Authors:  A P Vizcaino; D M Parkin; M E Skinner
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans.

Authors:  R Pacella-Norman; M I Urban; F Sitas; H Carrara; R Sur; M Hale; P Ruff; M Patel; R Newton; D Bull; V Beral
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

View more
  2 in total

1.  Descriptive analysis of esophageal cancer in Zambia using the cancer disease hospital database: young age, late stage at presentation.

Authors:  Akwi Wasi Asombang; Nancy Kasongo; John Muyutu; Joao Filipe Goncalves Montiero; Nathaniel Chishinga; Jackson Chipaila; Lewis Banda
Journal:  Pan Afr Med J       Date:  2021-05-04

2.  Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes.

Authors:  Akwi W Asombang; Nathaniel Chishinga; Alick Nkhoma; Jackson Chipaila; Bright Nsokolo; Martha Manda-Mapalo; Joao Filipe G Montiero; Lewis Banda; Kulwinder S Dua
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.